CA 19-9 quantitative rapid test  Kit is a chromatographic immunoassay for quantitative measurement of the CA 19-9 tumor associated antigen in human serum or plasma, is indicated for the serial measurement of CA 19-9 to aid in the management of patients diagnosed with cancers of the exocrine pancreas. The test is useful as an aid in: Monitoring of disease status in those patients having confirmed pancreatic cancer who have levels of serum or plasma CA19-9 above the cutoff, at the time of diagnosis.

CA 19-9 values must be interpreted in conjunction with all other available clinical and laboratory data before a medical decision is determined.